Literature DB >> 8804235

Restless legs syndrome in end-stage renal disease.

J W Winkelman1, G M Chertow, J M Lazarus.   

Abstract

The aim of this study was to evaluate the prevalence of restless legs syndrome (RLS) in patients with end-stage renal disease (ESRD), and to determine its association with sleep disorders and premature discontinuation of dialysis ("sign-offs"). End-stage renal disease patients (N = 204) and a control group of patients with heart disease (N = 129) completed a self-administered questionnaire regarding symptoms of RLS, sleep habits, pruritus, and adherence to dialysis therapy. Laboratory measures and sensory nerve amplitudes were collected on the ESRD patients. Twenty percent of the ESRD patients and 6% of the cardiac patients reported moderate to severe RLS symptomatology. Sleep onset was delayed and total sleep time was diminished in ESRD patients compared with cardiac patients. Symptoms of RLS were directly correlated with all sleep measures as well as with pruritus. Symptoms of RLS, sleep onset latency, and transferrin saturation were independently associated with premature discontinuation of dialysis. Significantly increased risk for mortality was observed in patients with RLS at the 2.5-year follow-up. Restless legs syndrome is a common finding in patients with ESRD and is associated with substantial morbidity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8804235     DOI: 10.1016/s0272-6386(96)90494-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  60 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Sleep physiology, abnormal States, and therapeutic interventions.

Authors:  Alvah T Wickboldt; Alex F Bowen; Aaron J Kaye; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2012

Review 3.  Management of restless legs syndrome in patients on dialysis.

Authors:  Miklos Z Molnar; Marta Novak; Istvan Mucsi
Journal:  Drugs       Date:  2006       Impact factor: 9.546

4.  Prospective study of restless legs syndrome and mortality among men.

Authors:  Yanping Li; Wei Wang; John W Winkelman; Atul Malhotra; Jing Ma; Xiang Gao
Journal:  Neurology       Date:  2013-06-12       Impact factor: 9.910

Review 5.  An update on the pathophysiology and genetics of restless legs syndrome.

Authors:  Lynn Marie Trotti; Srinivas Bhadriraju; David B Rye
Journal:  Curr Neurol Neurosci Rep       Date:  2008-07       Impact factor: 5.081

6.  Restless legs syndrome is underdiagnosed in the US Renal Data System.

Authors:  N G Kutner; R Zhang; D L Bliwise
Journal:  QJM       Date:  2013-01-28

Review 7.  Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients.

Authors:  Jennifer S Scherer; Sara A Combs; Frank Brennan
Journal:  Am J Kidney Dis       Date:  2016-09-29       Impact factor: 8.860

8.  Sleep disruption in patients with sleep apnea and end-stage renal disease.

Authors:  Andrea Loewen; AnDrea Siemens; Patrick Hanly
Journal:  J Clin Sleep Med       Date:  2009-08-15       Impact factor: 4.062

Review 9.  Sleep-associated movement disorders and heart failure.

Authors:  Troy Schaffernocker; Julia Ho; Don Hayes
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

Review 10.  Restless legs syndrome: differential diagnosis and management with pramipexole.

Authors:  Francesca Brindani; Francesca Vitetta; Franco Gemignani
Journal:  Clin Interv Aging       Date:  2009-06-29       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.